Geodon
NDC 64725-3920
Product Information
Geodon is a NDA-approved product labeled by Tya Pharmaceuticals. This medication is used to treat certain mental/mood disorders (schizophrenia, bipolar disorder). It is supplied as a product. This product entry covers the primary NDC 64725-3920 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 64725-3920?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ZIPRASIDONE MESYLATE (UNII: 3X6SAX83JZ)
- ZIPRASIDONE (UNII: 6UKA5VEJ6X) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- METHANESULFONIC ACID (UNII: 12EH9M7279)
- SULFOBUTYLETHER .BETA.-CYCLODEXTRIN (UNII: 2PP9364507)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 351223 - ziprasidone 20 MG Injection
- RxCUI: 351223 - ziprasidone (as ziprasidone mesylate) 20 MG Injection
- RxCUI: 352228 - Geodon 20 MG Injection
- RxCUI: 352228 - ziprasidone 20 MG Injection [Geodon]
- RxCUI: 352228 - Geodon (as ziprasidone mesylate) 20 MG Injection
* Please review the full disclaimer at the bottom of this page.